An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis

l-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis

(2014) Lorenzo Di Liberato et al.   JOURNAL OF NEPHROLOGY

Metabolomics signature improves the prediction of cardiovascular events in elderly subjects

(2013) S. Rizza et al.   ATHEROSCLEROSIS

The G Protein-Coupled Receptor 55 Ligandl-α-Lysophosphatidylinositol Exerts Microglia-Dependent Neuroprotection After Excitotoxic Lesion

(2013) Sonja Kallendrusch et al.   GLIA

Interleukin-1  Alters Glutamate Transmission at Purkinje Cell Synapses in a Mouse Model of Multiple Sclerosis

(2013) G. Mandolesi et al.   JOURNAL OF NEUROSCIENCE

A novel biological role for the phospholipid lysophosphatidylinositol in nociceptive sensitization via activation of diverse G-protein signalling pathways in sensory nerves in vivo

(2013) Vijayan Gangadharan et al.   PAIN

Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans

(2013) Anders Tisell et al.   PLoS One

Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism

(2012) Hugo Gonzalo et al.   JOURNAL OF NEUROCHEMISTRY

Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis

(2011) Jeffrey A. Cohen et al.   ANNALS OF NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Multiple sclerosis and pregnancy

(2011) Alex Tsui et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids

(2011) Sharon Anavi-Goffer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cytosolic Phospholipase A2  Blockade Abrogates Disease during the Tissue-Damage Effector Phase of Experimental Autoimmune Encephalomyelitis by Its Action on APCs

(2011) P. Thakker et al.   JOURNAL OF IMMUNOLOGY

Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis

(2011) Kathryn M. Brennan et al.   JOURNAL OF NEUROIMMUNOLOGY

Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis

(2011) Piero Del Boccio et al.   Journal of Proteomics

Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis

(2011) Marek J. Noga et al.   Metabolomics

New perspectives in the natural history of multiple sclerosis

(2010) H. Tremlett et al.   NEUROLOGY

Multiple sclerosis: Geoepidemiology, genetics and the environment

(2009) Ron Milo et al.   AUTOIMMUNITY REVIEWS

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

Cerebrospinal Fluid Secretory Ca2+-Dependent Phospholipase A2 Activity Is Increased in Alzheimer Disease

(2009) S. Chalbot et al.   CLINICAL CHEMISTRY

A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis

(2008) David Wheeler et al.   BRAIN

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

(2008) F. J. Quintana et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA